Neuropilin-1 (NRP1) expression distinguishes self-reactive helper T cells in systemic autoimmune disease

EMBO Mol Med. 2022 Oct 10;14(10):e15864. doi: 10.15252/emmm.202215864. Epub 2022 Sep 7.

Abstract

Pathogenic T helper cells (Th cells) that respond to self-antigen cannot be easily distinguished from beneficial Th cells. These cells can generate systemic autoimmune disease in response to widely expressed self-antigens. In this study, we have identified neuropilin-1 (NRP1) as a cell surface marker of self-reactive Th cells. NRP1+ Th cells, absent in non-regulatory T cell subsets in normal mice, appeared in models of systemic autoimmune disease and strongly correlated with disease symptoms. NRP1+ Th cells were greatly reduced in Nr4a2 cKO mice, which have reduced self-reactive responses but showed normal responses against exogenous antigens. Transfer of NRP1+ Th cells was sufficient to initiate or accelerate systemic autoimmune disease, and targeting NRP1-expressing Th cells therapeutically ameliorated SLE-like autoimmune symptoms in BXSB-Yaa mice. Peripheral NRP1+ Th cells were significantly increased in human SLE patients. Our data suggest that self-reactive Th cells can be phenotypically distinguished within the Th cell pool. These findings offer a novel approach to identify self-reactive Th cells and target them to treat systemic autoimmune disease.

Keywords: NR4A2; SLE; neuropilin-1; self-reactive T helper cells; systemic autoimmune disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Autoantigens
  • Autoimmune Diseases*
  • Humans
  • Mice
  • Neuropilin-1* / metabolism
  • T-Lymphocytes, Helper-Inducer / metabolism

Substances

  • Autoantigens
  • NRP1 protein, human
  • Neuropilin-1